Cas:408360-05-4 3-(4-methylphenyl)sulfonyl-1,3-thiazolidine-2-carboxylic acid manufacturer & supplier

Chemical Name:3-(4-methylphenyl)sulfonyl-1,3-thiazolidine-2-carboxylic acid

CAS.NO:408360-05-4

Synonyms:3-(4-methylphenyl)sulfonyl-1,3-thiazolidine-2-carboxylic acid

Molecular Formula:C₁₁H₁₃NO₄S₂

Molecular Weight:287.35500

HS Code:2934999090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:518.4ºC at 760mmHg

Density:N/A

Index of Refraction:

PSA:108.36000

Exact Mass:287.02900

LogP:2.16190

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3-(4-methylphenyl)sulfonyl-1,3-thiazolidine-2-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-(4-methylphenyl)sulfonyl-1,3-thiazolidine-2-carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-(4-methylphenyl)sulfonyl-1,3-thiazolidine-2-carboxylic acid Use and application,3-(4-methylphenyl)sulfonyl-1,3-thiazolidine-2-carboxylic acid technical grade,usp/ep/jp grade.

Related News: If the Justice Department concludes that an internal investigation was thorough, it can result in a non-prosecution agreement with few, if any, penalties, the experts said. However, a company-led investigation that appears to have been poorly handled could lead to harsher outcomes. 3-(4-methylphenyl)sulfonyl-1,3-thiazolidine-2-carboxylic acid manufacturer The vaccine also proved safe during the two-year trial, in which eleven doses were administered to randomly chosen patients with mild dementia. People who received the vaccine, known as AADvac1, experienced about the same numbers of side effects and adverse events as those who were given a placebo. 3-(4-methylphenyl)sulfonyl-1,3-thiazolidine-2-carboxylic acid supplier Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added ��The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova. 3-(4-methylphenyl)sulfonyl-1,3-thiazolidine-2-carboxylic acid vendor The vaccine also proved safe during the two-year trial, in which eleven doses were administered to randomly chosen patients with mild dementia. People who received the vaccine, known as AADvac1, experienced about the same numbers of side effects and adverse events as those who were given a placebo. 3-(4-methylphenyl)sulfonyl-1,3-thiazolidine-2-carboxylic acid factory The vaccine also proved safe during the two-year trial, in which eleven doses were administered to randomly chosen patients with mild dementia. People who received the vaccine, known as AADvac1, experienced about the same numbers of side effects and adverse events as those who were given a placebo.